IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+10.94%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(-13%)
Cap. Flow
-$28M
Cap. Flow
% of AUM
-18.49%
Top 10 Holdings %
Top 10 Hldgs %
41.58%
Holding
82
New
16
Increased
10
Reduced
28
Closed
20
Top Buys
| 1 |
Humana
HUM
|
$5.58M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$2.11M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$1.99M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$1.74M |
| 5 |
Puma Biotechnology
PBYI
|
$1.73M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.61M |
| 2 |
AET
Aetna Inc
AET
|
$4.53M |
| 3 |
Eli Lilly
LLY
|
$3.42M |
| 4 |
Glaukos
GKOS
|
$3.3M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$2.61M |
Sector Composition
| 1 | Healthcare | 82.78% |
| 2 | Energy | 0.61% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.11M | 1.37% |
+50,000
| New | +$2.11M |
|
27
Ionis Pharmaceuticals
IONS
$6.79B
| $2.01M | 1.31% |
40,000
+25,000
| +167% | +$1.26M |
|
|
28
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.99M | 1.3% |
+50,000
| New | +$1.99M |
|
29
Merus
MRUS
$4.98B
| $1.94M | 1.26% |
100,000
-40,000
| -29% | -$776K |
|
30
ADMA Biologics
ADMA
$4.12B
| $1.93M | 1.25% |
600,000
+35,000
| +6% | +$112K |
|
31
Pfizer
PFE
$141B
| $1.81M | 1.18% |
50,000
-10,000
| -17% | -$362K |
|
32
Wave Life Sciences
WVE
$1.53B
| $1.76M | 1.14% |
50,000
-5,000
| -9% | -$176K |
|
|
AKCA
33
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $1.74M | 1.13% |
+100,000
| New | +$1.74M |
|
|
34
Puma Biotechnology
PBYI
$254M
| $1.73M | 1.13% |
+17,500
| New | +$1.73M |
|
|
ARNA
35
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.7M | 1.11% |
50,000
-10,000
| -17% | -$340K |
|
36
Viatris
VTRS
$12.3B
| $1.69M | 1.1% |
+40,000
| New | +$1.69M |
|
|
AVXS
37
DELISTED
AveXis, Inc. Common Stock
AVXS
| $1.66M | 1.08% |
15,000
-2,500
| -14% | -$277K |
|
|
MDCO
38
DELISTED
Medicines Co
MDCO
| $1.64M | 1.07% |
60,000
-40,000
| -40% | -$1.09M |
|
|
AGN
39
DELISTED
Allergan plc
AGN
| $1.64M | 1.07% |
+10,000
| New | +$1.64M |
|
|
ABLX
40
DELISTED
Ablynx NV American Depositary Shares
ABLX
| $1.62M | 1.05% |
+65,000
| New | +$1.62M |
|
41
CytomX Therapeutics
CTMX
$336M
| $1.58M | 1.03% |
75,000
+5,000
| +7% | +$106K |
|
42
Boston Scientific
BSX
$156B
| $1.24M | 0.81% |
50,000
-75,000
| -60% | -$1.86M |
|
|
CTLT
43
DELISTED
CATALENT, INC.
CTLT
| $1.23M | 0.8% |
30,000
| – | – |
|
44
GSK
GSK
$79.9B
| $1.06M | 0.69% |
+30,000
| New | +$1.06M |
|
|
DPLO
45
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1M | 0.65% |
50,000
-10,000
| -17% | -$201K |
|
46
Regenxbio
RGNX
$451M
| $998K | 0.65% |
+30,000
| New | +$998K |
|
47
Incyte
INCY
$16.5B
| $947K | 0.62% |
+10,000
| New | +$947K |
|
|
LHCG
48
DELISTED
LHC Group LLC
LHCG
| $919K | 0.6% |
+15,000
| New | +$919K |
|
49
Viking Therapeutics
VKTX
$3.04B
| $913K | 0.59% |
+225,000
| New | +$913K |
|
|
CORI
50
DELISTED
Corium International, Inc.
CORI
| $865K | 0.56% |
90,000
-35,000
| -28% | -$336K |
|